The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
Jonuleit, H., Kühn, U., Müller, G., Steinbrink, K., Paragnik, L., Schmitt, E., Knop, J., & Enk, A. H. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271209 · Cited by 1,163
Peptides Naturally Presented by MHC Class I Molecules
Rammensee, H. G., Falk, K., & Rötzschke, O. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001241 · Cited by 799
Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
Honda, R., & Yasuda, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.1.22 · Cited by 724
Roth, J., Dobbelstein, M., Freedman, D. A., Shenk, T., & Levine, A. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.554 · Cited by 610
Vonderheide, R. H., Hahn, W. C., Schultze, J. L., & Nadler, L. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80066-7 · Cited by 570
A New Era for Cancer Immunotherapy Based on the Genes that Encode Cancer Antigens
Rosenberg, S. A. (1999) · Immunity · doi:10.1016/s1074-7613(00)80028-x · Cited by 566
Steinbrink, K., Jonuleit, H., Müller, G., Schuler, G., Knop, J., & Enk, A. H. (1999) · Blood · doi:10.1182/blood.v93.5.1634 · Cited by 511
Peptide ‘Velcro’: Design of a heterodimeric coiled coil
O'Shea, E. K., Lumb, K. J., & Kim, P. S. (1993) · Current Biology · doi:10.1016/0960-9822(93)90063-t · Cited by 437
Morel, S., Lévy, F., Burlet-Schiltz, O., Brasseur, F., Probst-Kepper, M., Peitrequin, A.-L., Monsarrat, B., Van Velthoven, R., Cerottini, J.-C., Boon, T., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80163-6 · Cited by 415
Clay, T. M., Custer, M. C., Sachs, J., Hwu, P., Rosenberg, S. A., & Nishimura, M. I. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.507 · Cited by 410
Eradication of Established Tumors by CD8+ T Cell Adoptive Immunotherapy
Hanson, H. L., Donermeyer, D. L., Ikeda, H., White, J. M., Shankaran, V., Old, L. J., Shiku, H., Schreiber, R. D., & Allen, P. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00026-1 · Cited by 358
Targeting p53 as a general tumor antigen.
Theobald, M., Biggs, J., Dittmer, D., Levine, A. J., & Sherman, L. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.11993 · Cited by 304
Self-citationIn vitro evolution of a T cell receptor with high affinity for peptide/MHC
Holler, P. D., Holman, P. O., Shusta, E. V., O'Herrin, S., Wittrup, K. D., & Kranz, D. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080078297 · Cited by 295
Coordinated Dual Cleavages Induced by the Proteasome Regulator PA28 Lead to Dominant MHC Ligands
Dick, T. P., Ruppert, T., Groettrup, M., Kloetzel, P. M., Kuehn, L., Koszinowski, U. H., Stevanovic, S., Schild, H., & Rammensee, H.-G. (1996) · Cell · doi:10.1016/s0092-8674(00)80097-5 · Cited by 280
Self-citationImmunotherapy through TCR gene transfer
Kessels, H. W. H. G., Wolkers, M. C., van den Boom, M. D., van den Valk, M. A., & Schumacher, T. N. M. (2001) · Nature Immunology · doi:10.1038/ni1001-957 · Cited by 279
Craiu, A., Akopian, T., Goldberg, A., & Rock, K. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10850 · Cited by 264
Tolerance to p53 by A2.1-restricted Cytotoxic T Lymphocytes
Theobald, M., Biggs, J., Hernández, J., Lustgarten, J., Labadie, C., & Sherman, L. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.833 · Cited by 256
Self-citationCytotoxic T cell immunity against telomerase reverse transcriptase in humans
Minev, B., Hipp, J., Firat, H., Schmidt, J. D., Langlade-Demoyen, P., & Zanetti, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070560797 · Cited by 255
Lower receptor avidity required for thymic clonal deletion than for effector T-cell function
Pircher, H., Rohrer, U. H., Moskophidis, D., Zinkernagel, R. M., & Hengartner, H. (1991) · Nature · doi:10.1038/351482a0 · Cited by 254
Two new proteases in the MHC class I processing pathway
Stoltze, L., Schirle, M., Schwarz, G., Schröter, C., Thompson, M. W., Hersh, L. B., Kalbacher, H., Stevanovic, S., Rammensee, H.-G., & Schild, H. (2000) · Nature Immunology · doi:10.1038/80852 · Cited by 249
Sijts, A. J. A. M., Ruppert, T., Rehermann, B., Schmidt, M., Koszinowski, U. H., & Kloetzel, P. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.503 · Cited by 183
Self-citationGrafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR
Willemsen, R. A., Weijtens, M. E. M., Ronteltap, C., Eshhar, Z., Gratama, J. W., Chames, P., & Bolhuis, R. L. H. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301253 · Cited by 170
Self-citationCooper, L. J. N., Kalos, M., Lewinsohn, D. A., Riddell, S. R., & Greenberg, P. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.8207-8212.2000 · Cited by 165
Chang, H. C., Bao, Z., Yao, Y., Tse, A. G. D., Goyarts, E. C., Madsen, M., Kawasaki, E. S., Brauer, P. P., Sacchettini, J. C., & Nathenson, S. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11408 · Cited by 148
Freedman, D. A., & Levine, A. J. (1999) · PubMed · Cited by 140
Theobald, M., Ruppert, T., Kuckelkorn, U., Hernández, J., Häußler, A., Ferreira, E. A., Liewer, U., Biggs, J., Levine, A. J., Huber, C., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1017 · Cited by 126
Self-citationEvidence from in vitro studies that tolerance to self antigens is MHC-restricted
Rammensee, H., & Bevan, M. J. (1984) · Nature · doi:10.1038/308741a0 · Cited by 117
Drexler, I., Antunes, E., Schmitz, M., Wölfel, T., Huber, C., Erfle, V., RIEBER, P., Theobald, M., & Sutter, G. (1999) · PubMed · Cited by 95
Self-citationChanging T cell specificity by retroviral T cell receptor display
Kessels, H. W. H. G., van den Boom, M. D., Spits, H., Hooijberg, E., & Schumacher, T. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14578 · Cited by 94
Stohwasser, R., Standera, S., Peters, I., Kloetzel, P., & Groettrup, M. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270520 · Cited by 77
Immunotherapy with CTLs restricted by nonself MHC
Stauss, H. J. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01443-7 · Cited by 72
Self-citation
Cited by
Parkhurst, M. R., Yang, J. C., Langan, R. C., Dudley, M. E., Nathan, D.-A. N., Feldman, S. A., Davis, J. L., Morgan, R. A., Merino, M. J., Sherry, R. M., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.272 · Cited by 1,020
Berger, C., Jensen, M. C., Lansdorp, P. M., Gough, M., Elliott, C., & Riddell, S. R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32103 · Cited by 824
Targeting tumours with genetically enhanced T lymphocytes
Sadelain, M., Rivière, I., & Brentjens, R. (2003) · Nature Reviews Cancer · doi:10.1038/nrc971 · Cited by 535
Gene-engineered T cells for cancer therapy
Kershaw, M. H., Westwood, J. A., & Darcy, P. K. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3565 · Cited by 505
Cohen, C. J., Zhao, Y., Zheng, Z., Rosenberg, S. A., & Morgan, R. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1450 · Cited by 469
Metadata
- Authors
- Stanislawski, T., Voss, R.-H., Lotz, C., Sadovnikova, E., Willemsen, R. A., Kuball, J., Ruppert, T., Bolhuis, R. L. H., Melief, C. J., Huber, C., Stauss, H. J., & Theobald, M.
- Venue
- Nature Immunology
- Published
- 2001-10-01
- Volume
- 2
- Issue
- 10
- Pages
- 962-970
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1540969335
- Cited by
- 362
- References
- 33
- FWCI
- 8.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.